Compare A & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | EXPE |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Transportation Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 26.1B |
| IPO Year | 1999 | 2005 |
| Metric | A | EXPE |
|---|---|---|
| Price | $113.81 | $244.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 29 |
| Target Price | $161.06 | ★ $275.37 |
| AVG Volume (30 Days) | 2.1M | ★ 2.9M |
| Earning Date | 05-27-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.90% | 0.79% |
| EPS Growth | 3.16 | ★ 9.61 |
| EPS | 1.07 | ★ 9.81 |
| Revenue | $4,472,000,000.00 | ★ $14,733,000,000.00 |
| Revenue This Year | $8.42 | $10.29 |
| Revenue Next Year | $6.12 | $6.97 |
| P/E Ratio | $106.52 | ★ $24.89 |
| Revenue Growth | 6.43 | ★ 7.61 |
| 52 Week Low | $96.43 | $130.01 |
| 52 Week High | $160.27 | $303.80 |
| Indicator | A | EXPE |
|---|---|---|
| Relative Strength Index (RSI) | 32.85 | 56.84 |
| Support Level | $112.53 | $211.89 |
| Resistance Level | $122.91 | $252.23 |
| Average True Range (ATR) | 3.03 | 10.37 |
| MACD | -0.16 | 3.60 |
| Stochastic Oscillator | 20.12 | 84.59 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.